Patients with pulmonary nontuberculous mycobacterial infections were more likely to have used inhaled corticosteroids than patients with other airway disease.
There were reductions in influenza cases, deaths, and costs by adding pharmacies during influenza epidemics.
Fewer than half of women who were pregnant during peak influenza vaccination period in 2017 to 2018 were vaccinated.
Larger cities with higher base transmission potentials have more diffuse influenza epidemics.
Influenza-related hospitalizations were reduced by 40% over 6 flu seasons.
Repeated exposure to the influenza virus affects antibody quantity and quality, and strains selected for seasonal vaccines may not provide coverage sufficient for individuals frequently infected and/or vaccinated.
Antipseudomonal combination therapy has shown poorer efficacy than antipseudomonal monotherapy in individuals with suspected pseudomonal pneumonia.
Elderly patients who have been inoculated with the influenza vaccine and who also use a statin are at a greater risk for medically attended acute respiratory illness.
The burden of childhood and infant pneumonia can be effectively reduced through the use of the pneumococcal Haemophilus influenzae protein D conjugate vaccine.
PCV13 in adults age <65 years with diabetes could reduce a substantial number of pneumonia hospitalizations.
NasoVAX, an adenovirus-based intranasal flu vaccine, shows tolerability, safety, and higher cellular immune response compared to an injectable vaccine.
When compared to placebo, baloxavir marboxil was associated with reduced risk of influenza complications and faster recovery.
Findings may highlight physician difficulty explaining to patients why antibiotics are not required.
The use of fluoroquinolones in stable patients with community-acquired pneumonia can be reduced with stewardship programs that share antibiotic use data and provide guidance for step-down therapy.
The FDA has approved Nuzyra for the treatment of adult patients with CABP and acute bacterial skin and skin structure infections.
For patients with CAP, antibiotic regimens including a fluoroquinolone may reduce mortality risk by 1-2% compared to beta-lactams and cephalosporins alone.
Active Choice Intervention Effective in Increasing Influenza Vaccination Rates at Primary Care Practices
Influenza vaccination rates decline as the clinic day progresses.
Patients with acute respiratory distress syndrome and confirmed influenza diagnosis treated ≤6 hours with oseltamivir had reduced length of hospital stay and a lower rate of mortality.
Wide variations in influenza vaccine coverage have been noted across healthcare personnel based on occupation and worksite.
Previous antibiotic use and mechanical invasive ventilation were risk factors for multidrug-resistant pathogens in hospital-associated or ventilator-associated pneumonia.